Provided by Tiger Trade Technology Pte. Ltd.

Inhibrx Biosciences

103.63
+4.484.52%
Post-market: 103.630.00000.00%19:30 EDT
Volume:220.74K
Turnover:22.72M
Market Cap:1.52B
PE:-11.67
High:105.65
Open:100.76
Low:99.05
Close:99.15
52wk High:155.29
52wk Low:24.00
Shares:14.67M
Float Shares:8.42M
Volume Ratio:0.75
T/O Rate:2.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.8768
EPS(LYR):-9.0434
ROE:-1773.60%
ROA:-43.61%
PB:-28.70
PE(LYR):-11.46

Loading ...

Jun 15, 2024

Correspondence

Form CORRESP - Correspondence
Jun 11, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jun 07, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 03, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Jun 03, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Jun 03, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
May 31, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 30, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 30, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 30, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 30, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 30, 2024

Major Issues Report

Form 8-K - Current report
May 30, 2024

Delisting

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
May 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 24, 2024

Major Issues Report

Form 8-K - Current report
May 23, 2024

Correspondence

Form CORRESP - Correspondence
May 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]